ConductScience.org, home
ALKBH5: alkB homolog 5, RNA demethylase
API referenceFor AI assistants

Gene · 54890

Papers4,144

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

141 to 160 of 4,144

Download this page as JSON
TitleJournalYearPMIDFound bySource
Lipid metabolism in homeostasis and disease.Signal Transduct Target Ther202641692800PubTator, text miningPubMed
RMzyme: regulations of RNA-modifying enzymes in humans.Signal Transduct Target Ther202641672979PubTator, text miningPubMed
Neural-tumor crosstalk and molecular targeting: mechanisms and therapeutic implications in cancer neuroscience.Cell Oncol (Dordr)202641627681PubTator, text miningPubMed
N6-methyladenosine RNA methylation regulators and their target SOX2 as circulating biomarkers of colorectal cancer: Insights towards early diagnosis and staging.Comput Biol Med202641621400PubTator, text miningPubMed
Redox-sensitive N6-methyladenosine RNA epitranscriptomic mechanisms in environmental stress and hazard.Redox Biol202641616571PubTator, text miningPubMed
The SAM-m6A axis as an unexplored therapeutic hub for plant-derived regulation of disease metabolism.Pharmacol Res202641611142PubTator, text miningPubMed
A system-level metastable model of cancer evolution: integrating replication stress, cell cycle deregulation and chromosomal instability.Ann Med202641606986PubTator, text miningPubMed
Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression.Cancer Biol Ther202641606955PubTator, text miningPubMed
Tendon Organoids Enable Functional Tendon Rejuvenation Through ALKBH5-Dependent RNA Demethylation.Adv Sci (Weinh)202641603230PubTator, text miningPubMed
Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications.Biomark Res202641593811PubTator, text miningPubMed
Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment.Exp Hematol Oncol202641588554PubTator, text miningPubMed
Identifying a Novel Six-LncRNA Signature Evaluates Survival and Reveals AC129507.1 as the m6A-Target to Regulate Ferroptosis in Gastric Cancer.J Gastroenterol Hepatol202641575492PubTator, text miningPubMed
Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review).Int J Mol Med202641574706PubTator, text miningPubMed
IDH1 Reprograms Nucleotide Metabolism by Inducing Chromatin Remodeling and DHODH Transcription to Drive Chemoresistance in Nasopharyngeal Carcinoma.Cancer Res202641570327PubTator, text miningPubMed
Reply to letter to the editor questions and comments on "ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation".Pharmacol Res202641564987PubTator, text miningPubMed
Tongmai Yangxin Pill ameliorates doxorubicin-induced cardiotoxicity through m6A/ALKBH5/BNIP3 axis.J Ethnopharmacol202641554447PubTator, text miningPubMed
Questions and comments on "ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation," published in Pharmacological Research (2023).Pharmacol Res202641554350PubTator, text miningPubMed
The AHCY-adenosine complex rewires mRNA methylation to enhance fatty acid biosynthesis and tumorigenesis.Cell Res202641549122PubTator, text miningPubMed
CircRM: profiling circular RNA modifications from nanopore direct RNA sequencing.Brief Bioinform202641529120PubTator, text miningPubMed
Diabetic Kidney Disease Progression Alleviated in Mice by ALKBH5-Mediated UC-MSCs-Derived Exosomes That Inhibit TRAF6 m6A Modification and Promote M2 Macrophage Polarisation.Endocrinol Diabetes Metab202641527491PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/54890/papers?page=8

API referenceFor AI assistants